Increase in the cytotoxicity of 1-beta-D-arabinofuranosylcytosine due to inhibition of degradation of its triphosphate by hydroxyurea in Burkitt's lymphoma cells.
作者信息
Abe I, Saito S, Suzuki M, Sato H
出版信息
Gan. 1981 Apr;72(2):337-8.
PMID:7286558
Abstract
摘要
相似文献
1
2
3
Prediction of sensitivity to 1-beta-D-arabinofuranosylcytosine by the plateau level of its 5'-triphosphate in human lymphoblastic cell lines in vitro.体外人淋巴细胞系中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸的平台水平对其敏感性的预测
Eur J Cancer Clin Oncol. 1983 Jul;19(7):941-4. doi: 10.1016/0277-5379(83)90062-7.
4
Ara-CTP metabolism following hydroxyurea or methotrexate treatment in human leukemia cell lines.羟基脲或甲氨蝶呤治疗人白血病细胞系后的阿糖胞苷三磷酸（Ara-CTP）代谢
Adv Exp Med Biol. 1989;253B:363-7. doi: 10.1007/978-1-4684-5676-9_53.
5
6
Degradation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human leukemic myeloblasts and lymphoblasts.
Cancer Res. 1987 Jun 15;47(12):3130-5.
7
Differential modulation of 1-beta-D-arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines.羟基脲对人白血病细胞系中1-β-D-阿拉伯呋喃糖基胞嘧啶代谢的差异调节作用
Biochem Pharmacol. 1988 May 1;37(9):1745-9. doi: 10.1016/0006-2952(88)90438-8.
8
Dephosphorylation of nucleotides of 1-beta-D-arabinofuranosylcytosine in relation to the different drug sensitivity in tumor cells.1-β-D-阿拉伯呋喃糖基胞嘧啶核苷酸的去磷酸化与肿瘤细胞中不同药物敏感性的关系
Tohoku J Exp Med. 1979 Mar;127(3):281-8. doi: 10.1620/tjem.127.281.
9
10
Cellular pharmacology and optimal therapeutic concentrations of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic blasts during treatment of refractory leukemia with high-dose 1-beta-D-arabinofuranosylcytosine.大剂量1-β-D-阿拉伯呋喃糖基胞嘧啶治疗难治性白血病期间白血病母细胞中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸的细胞药理学及最佳治疗浓度
Scand J Haematol Suppl. 1986;44:51-9. doi: 10.1111/j.1600-0609.1986.tb01590.x.
Zotero 插件